328 related articles for article (PubMed ID: 27760180)
1. Clinical Nomogram for Predicting Survival Outcomes in Early Mucinous Breast Cancer.
Fu J; Wu L; Jiang M; Li D; Jiang T; Hong Z; Wang F; Li S
PLoS One; 2016; 11(10):e0164921. PubMed ID: 27760180
[TBL] [Abstract][Full Text] [Related]
2. The clinical features and prognosis of patients with mucinous breast carcinoma compared with those with infiltrating ductal carcinoma: a population-based study.
Zhou X; Zheng Z; Li Y; Zhao W; Lin Y; Zhang J; Sun Q
BMC Cancer; 2021 May; 21(1):536. PubMed ID: 33975551
[TBL] [Abstract][Full Text] [Related]
3. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.
Di Saverio S; Gutierrez J; Avisar E
Breast Cancer Res Treat; 2008 Oct; 111(3):541-7. PubMed ID: 18026874
[TBL] [Abstract][Full Text] [Related]
4. Early and Locally Advanced Metaplastic Breast Cancer: Presentation and Survival by Receptor Status in Surveillance, Epidemiology, and End Results (SEER) 2010-2014.
Schroeder MC; Rastogi P; Geyer CE; Miller LD; Thomas A
Oncologist; 2018 Apr; 23(4):481-488. PubMed ID: 29330212
[TBL] [Abstract][Full Text] [Related]
5. Nomogram for predicting preoperative regional lymph nodes metastasis in patients with metaplastic breast cancer: a SEER population-based study.
Zhang M; Wang B; Liu N; Wang H; Zhang J; Wu L; Zhao A; Wang L; Zhao X; Yang J
BMC Cancer; 2021 May; 21(1):565. PubMed ID: 34001061
[TBL] [Abstract][Full Text] [Related]
6. A novel nomogram and risk classification system for predicting lymph node metastasis of breast mucinous carcinoma: A SEER-based study.
Wu SL; Gai JD; Yu XM; Mao X; Jin F
Cancer Med; 2022 Dec; 11(24):4767-4783. PubMed ID: 35599552
[TBL] [Abstract][Full Text] [Related]
7. Survival outcomes of metaplastic breast cancer patients: results from a US population-based analysis.
Nelson RA; Guye ML; Luu T; Lai LL
Ann Surg Oncol; 2015 Jan; 22(1):24-31. PubMed ID: 25012264
[TBL] [Abstract][Full Text] [Related]
8. A prognostic model of patients with ovarian mucinous adenocarcinoma: a population-based analysis.
Yang L; Yu J; Zhang S; Shan Y; Li Y; Xu L; Zhang J; Zhang J
J Ovarian Res; 2022 Feb; 15(1):26. PubMed ID: 35168642
[TBL] [Abstract][Full Text] [Related]
9. Overall Survival of Men and Women With Breast Cancer According to Tumor Subtype: A Population-based Study.
Leone J; Zwenger AO; Leone BA; Vallejo CT; Leone JP
Am J Clin Oncol; 2019 Feb; 42(2):215-220. PubMed ID: 30499840
[TBL] [Abstract][Full Text] [Related]
10. Difference in characteristics and outcomes between medullary breast carcinoma and invasive ductal carcinoma: a population based study from SEER 18 database.
Wang XX; Jiang YZ; Liu XY; Li JJ; Song CG; Shao ZM
Oncotarget; 2016 Apr; 7(16):22665-73. PubMed ID: 27009810
[TBL] [Abstract][Full Text] [Related]
11. The effect of Paget disease on axillary lymph node metastases and survival in invasive ductal carcinoma.
Wong SM; Freedman RA; Sagara Y; Stamell EF; Desantis SD; Barry WT; Golshan M
Cancer; 2015 Dec; 121(24):4333-40. PubMed ID: 26376021
[TBL] [Abstract][Full Text] [Related]
12. Outcome of pure mucinous breast carcinoma compared to infiltrating ductal carcinoma: a population-based study from China.
Cao AY; He M; Liu ZB; Di GH; Wu J; Lu JS; Liu GY; Shen ZZ; Shao ZM
Ann Surg Oncol; 2012 Sep; 19(9):3019-27. PubMed ID: 22451233
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the prognosis of medullary breast carcinoma and invasive ductal carcinoma: a SEER-based study.
Chen Y; Xu Z; Chen Y; Dai Y; Ding J
Transl Cancer Res; 2024 Jan; 13(1):231-248. PubMed ID: 38410238
[TBL] [Abstract][Full Text] [Related]
14. Prognostic markers for invasive micropapillary carcinoma of the breast: a population-based analysis.
Chen AC; Paulino AC; Schwartz MR; Rodriguez AA; Bass BL; Chang JC; Teh BS
Clin Breast Cancer; 2013 Apr; 13(2):133-9. PubMed ID: 23246269
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic characteristics at diagnosis and the survival of patients with medullary breast carcinoma in China: a comparison with infiltrating ductal carcinoma-not otherwise specified.
Cao AY; He M; Huang L; Shao ZM; Di GH
World J Surg Oncol; 2013 Apr; 11():91. PubMed ID: 23607710
[TBL] [Abstract][Full Text] [Related]
16. Predictors for Survival and Distribution of 21-Gene Recurrence Score in Patients With Pure Mucinous Breast Cancer: A SEER Population-Based Retrospective Analysis.
Ding S; Wu J; Lin C; Chen W; Li Y; Shen K; Zhu L
Clin Breast Cancer; 2019 Feb; 19(1):e66-e73. PubMed ID: 30396812
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics and overall survival prognostic nomogram for metaplastic breast cancer.
Zheng C; Fu C; Wen Y; Liu J; Lin S; Han H; Han Z; Xu C
Front Oncol; 2023; 13():1030124. PubMed ID: 36937402
[TBL] [Abstract][Full Text] [Related]
18. Comparative prognostic analysis for triple-negative breast cancer with metaplastic and invasive ductal carcinoma.
Li Y; Zhang N; Zhang H; Yang Q
J Clin Pathol; 2019 Jun; 72(6):418-424. PubMed ID: 30872384
[TBL] [Abstract][Full Text] [Related]
19. Nomogram to predict overall survival and disease-specific survival with appendiceal mucinous adenocarcinoma.
Yan Q; Zheng WJ; Chen QL; Wang BQ; Luo HY; Xue J; Wang XW
Medicine (Baltimore); 2019 Oct; 98(40):e17332. PubMed ID: 31577727
[TBL] [Abstract][Full Text] [Related]
20. Risk factors, prognostic factors, and nomograms for bone metastasis in patients with newly diagnosed infiltrating duct carcinoma of the breast: a population-based study.
Huang Z; Hu C; Liu K; Yuan L; Li Y; Zhao C; Hu C
BMC Cancer; 2020 Nov; 20(1):1145. PubMed ID: 33238981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]